Rizzo, M., Cosentino, F., Mantzoros, C. (2022). Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetes. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 15(7), 795-797 [10.1080/17512433.2022.2108400].

Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetes

Rizzo, Manfredi
;
2022-07-01

lug-2022
Rizzo, M., Cosentino, F., Mantzoros, C. (2022). Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetes. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 15(7), 795-797 [10.1080/17512433.2022.2108400].
File in questo prodotto:
File Dimensione Formato  
2022 Exp Rev Clin Pharmacol.pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 468.73 kB
Formato Adobe PDF
468.73 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/584518
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact